
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $222M | -- | -- | $0.68 | -- |
07/24/2025 | Q2 | $219.9M | -- | -- | $0.68 | -- |
04/24/2025 | Q1 | $215M | $200.4M | $0.54 | $0.63 | -$0.09 |
01/23/2025 | Q4 | $216.3M | $224.3M | $0.68 | $0.65 | $0.03 |
10/24/2024 | Q3 | $214.3M | $201.3M | $0.55 | $0.66 | -$0.11 |
07/25/2024 | Q2 | $205.7M | $214.8M | $0.64 | $0.59 | $0.05 |
04/25/2024 | Q1 | $201.1M | $195.3M | $0.53 | $0.59 | -$0.06 |
01/25/2024 | Q4 | $207.3M | $200.8M | $0.60 | $0.61 | -$0.01 |
10/24/2023 | Q3 | $209.7M | $212.1M | $0.66 | $0.67 | -$0.01 |
07/20/2023 | Q2 | $212M | $212.5M | $0.69 | $0.70 | -$0.01 |
04/20/2023 | Q1 | -- | $214.9M | $0.74 | -- | -- |
01/26/2023 | Q4 | -- | $213.9M | $0.73 | -- | -- |
10/20/2022 | Q3 | -- | $180.4M | $0.59 | -- | -- |
07/21/2022 | Q2 | -- | $166.8M | $0.55 | -- | -- |
04/21/2022 | Q1 | -- | $147.6M | $0.44 | -- | -- |
01/27/2022 | Q4 | -- | $156.5M | $0.50 | -- | -- |
10/21/2021 | Q3 | -- | $155.9M | $0.63 | -- | -- |
07/22/2021 | Q2 | -- | $157M | $0.52 | -- | -- |
04/21/2021 | Q1 | -- | $154.2M | $0.48 | -- | -- |
01/28/2021 | Q4 | -- | $180M | $0.49 | -- | -- |
10/21/2020 | Q3 | -- | $161.7M | $0.42 | -- | -- |
07/23/2020 | Q2 | -- | $154.3M | $0.38 | -- | -- |
04/20/2020 | Q1 | -- | $149.7M | $0.29 | -- | -- |
01/23/2020 | Q4 | -- | $155.7M | $0.49 | -- | -- |
10/17/2019 | Q3 | -- | $154.7M | $0.51 | -- | -- |
07/18/2019 | Q2 | -- | $156.9M | $0.53 | -- | -- |
04/25/2019 | Q1 | -- | $148.3M | $0.47 | -- | -- |
01/23/2019 | Q4 | -- | $155.5M | $0.56 | -- | -- |
10/18/2018 | Q3 | -- | $152.2M | $0.51 | -- | -- |
07/19/2018 | Q2 | -- | $152.2M | $0.37 | -- | -- |
04/19/2018 | Q1 | -- | $92.8M | $0.49 | -- | -- |
01/18/2018 | Q4 | -- | $94M | $0.40 | -- | -- |
10/20/2017 | Q3 | -- | $93.4M | $0.40 | -- | -- |
07/25/2017 | Q2 | -- | $86M | $0.37 | -- | -- |
04/21/2017 | Q1 | -- | $86.3M | $0.39 | -- | -- |
01/20/2017 | Q4 | -- | $87.1M | $0.38 | -- | -- |
10/21/2016 | Q3 | -- | $85.8M | $0.37 | -- | -- |
07/21/2016 | Q2 | -- | $87.3M | $0.36 | -- | -- |
04/21/2016 | Q1 | -- | $82.1M | $0.32 | -- | -- |
01/21/2016 | Q4 | -- | $79.6M | $0.32 | -- | -- |
10/22/2015 | Q3 | -- | $84.5M | $0.30 | -- | -- |
First Financial Bancorp reported $200.4M worth of top line sales in its most recent quarter.
First Financial Bancorp announced earnings per share of $0.54 which represents a miss of analyst forecast a $0.63 per share.
First Financial Bancorp reported -- that represents -- per share over the last quarter.
First Financial Bancorp's earnings are forecast to grow from $2.40 per share to $2.50 per share next year representing an increase of 10.08%.
First Financial Bancorp's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.